Showing results (31-40 of 157) with videos related to
Sort By:
Pageof 16
Expert Opinion on Drug Metabolism & Toxicology|December 18, 2025
Abuse liability of dextromethorphan and its combinatory formulation dextromethorphan/bupropion: a pharmacologic perspectiveYang Jing Zheng, Christine E Dri, Sabrina Wong, et al.Expert Opinion on Drug Safety|May 3, 2022
A review of potential neuropathological changes associated with ketamineDanica Nogo, Hana Nazal, Yuetong Song, et al.Journal of Geriatric Psychiatry and Neurology|May 8, 2025
Evaluating Suicidal Ideation and Anhedonic Symptoms in Obstructive Sleep Apnea Patients with InsomniaHayun Choi, Gia Han Le, Kayla M Teopiz, et al.Journal of Affective Disorders|February 13, 2021
Affective Temperament Traits Measured by TEMPS-A and Their Associations with Cognitive Functions among Offspring of Parents with Bipolar Disorder with and without Subthreshold SymptomsTao Liu, Guiyun Xu, Weicong Lu, et al.Journal of Psychiatric Research|February 16, 2025
The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: A systematic reviewKyle Valentino, Kayla M Teopiz, William Cheung, et al.Frontiers in Psychiatry|December 6, 2021
The Association Between Concentrations of Arginine, Ornithine, Citrulline and Major Depressive Disorder: A Meta-AnalysisMingyue Fan, Xiao Gao, Li Li, et al.Journal of Affective Disorders|January 1, 2023
Association between bullying victimization, coping style, and mental health problems among Chinese adolescentsWenjian Lai, Wenyan Li, Lan Guo, et al.BMC Psychiatry|November 30, 2022
The association of FKBP5 gene methylation, adolescents' sex, and depressive symptoms among Chinese adolescents: a nested case-control studyWenyan Li, Wanxin Wang, Wenjian Lai, et al.BMC Psychiatry|March 21, 2023
Childhood maltreatment and subsequent depressive symptoms: a prospective study of the sequential mediating role of self-esteem and internalizing/externalizing problemsWenyan Li, Wenjian Lai, Lan Guo, et al.Expert Review of Clinical Pharmacology|October 21, 2023
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophreniaJie Wu, Angela Th Kwan, Taeho Greg Rhee, et al.Pageof 16